GB9719754D0 - Organic compositions - Google Patents

Organic compositions

Info

Publication number
GB9719754D0
GB9719754D0 GBGB9719754.5A GB9719754A GB9719754D0 GB 9719754 D0 GB9719754 D0 GB 9719754D0 GB 9719754 A GB9719754 A GB 9719754A GB 9719754 D0 GB9719754 D0 GB 9719754D0
Authority
GB
United Kingdom
Prior art keywords
organic compositions
compositions
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9719754.5A
Other versions
GB2329334A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt and Colman Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Products Ltd filed Critical Reckitt and Colman Products Ltd
Priority to GB9719754A priority Critical patent/GB2329334A/en
Publication of GB9719754D0 publication Critical patent/GB9719754D0/en
Publication of GB2329334A publication Critical patent/GB2329334A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB9719754A 1997-09-18 1997-09-18 Cholesterol-lowering agents Withdrawn GB2329334A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9719754A GB2329334A (en) 1997-09-18 1997-09-18 Cholesterol-lowering agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9719754A GB2329334A (en) 1997-09-18 1997-09-18 Cholesterol-lowering agents

Publications (2)

Publication Number Publication Date
GB9719754D0 true GB9719754D0 (en) 1997-11-19
GB2329334A GB2329334A (en) 1999-03-24

Family

ID=10819202

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9719754A Withdrawn GB2329334A (en) 1997-09-18 1997-09-18 Cholesterol-lowering agents

Country Status (1)

Country Link
GB (1) GB2329334A (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
PL348580A1 (en) 1998-12-23 2002-06-03 Searle Llc Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
ES2189529T3 (en) 1998-12-23 2003-07-01 Searle Llc INHIBITOR COMBINATIONS FOR THE TRANSPORT OF BILIAR ACIDS IN THE ILEON AND COMPLEXING AGENTS FOR CARDIOVASCULAR INDICATIONS.
EP1342475A1 (en) 1998-12-23 2003-09-10 G.D. Searle LLC. Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
CN1338944A (en) 1998-12-23 2002-03-06 G.D.瑟尔有限公司 Cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
PT1140184E (en) 1998-12-23 2003-10-31 Searle Llc COMBINATIONS OF ESTER TRANSFER PROTEIN INHIBITORS OF CHOLESTEROL WITH NICOTINIC ACID DERIVATIVES FOR CARDIOVASCULAR INDICATIONS
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
WO2000038723A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
AU3988099A (en) * 1999-05-13 2000-12-05 Geltex Pharmaceuticals, Inc. Combination therapy for treating hypercholesterolemia
WO2000069446A1 (en) * 1999-05-13 2000-11-23 Geltex Pharmaceuticals, Inc. Combination therapy for treating hypercholesterolemia
US6794544B2 (en) 2000-03-10 2004-09-21 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
AU2001256278A1 (en) * 2000-04-18 2001-10-30 Bayer Aktiengesellschaft Use of cse inhibitors for treating heart failure
GB2373438A (en) * 2001-02-10 2002-09-25 Reckitt & Colmann Prod Ltd Cholesterol lowering compositions
JP2005518347A (en) 2001-11-02 2005-06-23 ジー．ディー． サール エルエルシー Novel mono- and difluorobenzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
MXPA04006255A (en) 2002-01-17 2004-09-27 Pharmacia Corp Novel alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake.
CA2379887C (en) * 2002-04-09 2004-01-20 Bernard Charles Sherman Stable tablets comprising simvastatin
BR0313186A (en) * 2002-07-23 2005-06-21 Nutrinova Gmbh Cholesterol lowering agent from dietary fiber and cholesterol lowering substances
CA2517572C (en) 2003-03-07 2011-12-13 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
MXPA05009503A (en) 2003-03-07 2005-10-18 Schering Corp Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia.
WO2005021038A2 (en) * 2003-08-27 2005-03-10 Beisel Guenther Agent for treating metabolic syndrome
US20050250734A1 (en) * 2003-11-07 2005-11-10 The Procter & Gamble Company Compositions, kits, and methods for the treatment of conditions associated with elevated cholesterol levels
CN111870639A (en) * 2020-08-11 2020-11-03 江西中医药大学 Application of Tibetan medicine scindapsus aureus in preparing medicine for treating atherosclerosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859703A (en) * 1987-06-15 1989-08-22 Warner-Lambert Company Lipid regulating compositions
US4885314A (en) * 1987-06-29 1989-12-05 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
CA2040996A1 (en) * 1990-05-02 1991-11-03 Robert L. Albright Composition and method for controlling cholesterol
TW227552B (en) * 1990-07-06 1994-08-01 Squibb & Sons Inc
IT1251153B (en) * 1991-08-06 1995-05-04 Vectorpharma Int SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION HAVING PROHIBITED GASTRIC RESIDENCE
JP3852621B2 (en) * 1992-01-21 2006-12-06 あすか製薬株式会社 Vascular endothelial cell function improving agent
US5451397A (en) * 1992-12-21 1995-09-19 Rohm And Haas Company Bile acid sequestrant
HU212428B (en) * 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl

Also Published As

Publication number Publication date
GB2329334A (en) 1999-03-24

Similar Documents

Publication Publication Date Title
GB9709082D0 (en) Organic compositions
GB9719754D0 (en) Organic compositions
GB9814234D0 (en) Organic composition
ZA983707B (en) Organic compositions
GB9702238D0 (en) Compositions
GB2324725B (en) Organic compositions
GB9623377D0 (en) Organic compositions
GB9625759D0 (en) Organic compositions
GB9610122D0 (en) Organic compositions
GB2324724B (en) Organic compositions
GB9703109D0 (en) Compositions
GB9705340D0 (en) Compositions
GB9708845D0 (en) Organic compositions
GB9719753D0 (en) Organic compositions
GB9717627D0 (en) Organic compositions
GB9717626D0 (en) Organic compositions
GB9713798D0 (en) Organic compositions
GB9713175D0 (en) Organic compositions
GB2329184B (en) Organic pigment compositions
GB9712981D0 (en) Compositions
GB9622252D0 (en) Organic compositions
GB9618616D0 (en) Organic compositions
GB9618614D0 (en) Organic compositions
GB9612020D0 (en) Organic compositions
GB9815234D0 (en) Organic compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)